Abstract
A de novo IL2/IL15 mimic has improved antitumor activity and reduced toxicity compared with native IL2.
- ©2019 American Association for Cancer Research.
Log in using your username and password
Purchase Short Term Access
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
March 2019
Volume 9, Issue 3
Volume 9, Issue 3
De Novo Cytokine Mimics Have Improved Therapeutic Properties
Jump to section
Advertisement